ARCHIVES

HHS Debars Straus, Who Concedes “Serious Deficiencies” In Trials

This article is from The Cancer Letter archive.

Vol. 08 No. 21 | May 21, 1982

Download PDF Visit The Full Archive

Related Articles

Amgen Agrees To Buy Immunex For $16 Billion In Stock And Cash.

January 25, 2002

Translational Research Needs Coordination, Budget, Advisors Say. Former SWOG Chairman Hoogstraten Publishes Memoir.

June 23, 2006

Estrogen-Only HRT Little Risk In Endometrial Cancer, GOG Study Indicates

March 26, 2004

ASCO Breaks Ground For New HQ.

August 4, 2006

Breast Cancer Coalition Seeks Continued DOD Funding For Research

July 2, 1993

Phase II Imbruvica Trial Shows 47% of MCL Patients Alive at 27-Month Median Follow-up

December 26, 2014